-
ICD-10-CM Codes
›
-
D50-D89
›
-
D60-D64
›
-
D61-
›
-
2023 ICD-10-CM Diagnosis Code D61.82
2023 ICD-10-CM Diagnosis Code D61.82
Myelophthisis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- D61.82 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM D61.82 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D61.82 - other international versions of ICD-10 D61.82 may differ.
Applicable To- Leukoerythroblastic anemia
- Myelophthisic anemia
- Panmyelophthisis
Code AlsoCode Also Help
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D61.82. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- idiopathic myelofibrosis (
ICD-10-CM Diagnosis Code D47.1
Chronic myeloproliferative disease
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
- myelofibrosis NOS (
ICD-10-CM Diagnosis Code D75.81
Myelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Manifestation Code
Applicable To- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Code First- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Type 1 Excludes- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Use Additional- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
- myelofibrosis with myeloid metaplasia (
ICD-10-CM Diagnosis Code D47.4
Osteomyelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic idiopathic myelofibrosis
- Myelofibrosis (idiopathic) (with myeloid metaplasia)
- Myelosclerosis (megakaryocytic) with myeloid metaplasia
- Secondary myelofibrosis in myeloproliferative disease
- primary myelofibrosis (
ICD-10-CM Diagnosis Code D47.1
Chronic myeloproliferative disease
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
- secondary myelofibrosis (
ICD-10-CM Diagnosis Code D75.81
Myelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Manifestation Code
Applicable To- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Code First- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Type 1 Excludes- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Use Additional- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
The following code(s) above
D61.82 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D61.82:
- Anemia, myelophthisic
- Myelophthisic anemia
Clinical Information
- Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.
ICD-10-CM D61.82 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Convert D61.82 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to D61.82:
-
Type 1 Excludes: D47.1, D47.1, D61.81, D61.81, D75.81, D75.81, D75.81
ICD-10-CM Diagnosis Code D47.1
Chronic myeloproliferative disease
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
ICD-10-CM Diagnosis Code D47.1
Chronic myeloproliferative disease
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Type 1 Excludes- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
ICD-10-CM Diagnosis Code D61.81
Pancytopenia
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- pancytopenia (due to) (with) aplastic anemia (D61.9)
- pancytopenia (due to) (with) bone marrow infiltration (D61.82)
- pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
- pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
- pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
- pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
- pancytopenia (due to) (with) myeloproliferative disease (D47.1)
Type 2 Excludes- pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
ICD-10-CM Diagnosis Code D61.81
Pancytopenia
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- pancytopenia (due to) (with) aplastic anemia (D61.9)
- pancytopenia (due to) (with) bone marrow infiltration (D61.82)
- pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
- pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
- pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
- pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
- pancytopenia (due to) (with) myeloproliferative disease (D47.1)
Type 2 Excludes- pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
ICD-10-CM Diagnosis Code D75.81
Myelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Manifestation Code
Applicable To- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Code First- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Type 1 Excludes- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Use Additional- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
ICD-10-CM Diagnosis Code D75.81
Myelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Manifestation Code
Applicable To- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Code First- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Type 1 Excludes- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Use Additional- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
ICD-10-CM Diagnosis Code D75.81
Myelofibrosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Manifestation Code
Applicable To- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Code First- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Type 1 Excludes- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Use Additional- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
ICD-10-CM Diagnosis Code D64.9
Anemia, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- normocytic (infectional) D64.9
ICD-10-CM Diagnosis Code D64.9
Anemia, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- leukoerythroblastic D61.82
- myelophthisic D61.82
- Myelophthisis D61.82
- Panmyelophthisis D61.82
ICD-10-CM Codes Adjacent To D61.82
D61.01 Constitutional (pure) red blood cell aplasia
D61.09 Other constitutional aplastic anemia
D61.1 Drug-induced aplastic anemia
D61.2 Aplastic anemia due to other external agents
D61.3 Idiopathic aplastic anemia
D61.8 Other specified aplastic anemias and other bone marrow failure syndromes
D61.810 Antineoplastic chemotherapy induced pancytopenia
D61.811 Other drug-induced pancytopenia
D61.82
Myelophthisis
D61.89 Other specified aplastic anemias and other bone marrow failure syndromes
D61.9 Aplastic anemia, unspecified
D62 Acute posthemorrhagic anemia
D63 Anemia in chronic diseases classified elsewhere
D63.0 Anemia in neoplastic disease
D63.1 Anemia in chronic kidney disease
D63.8 Anemia in other chronic diseases classified elsewhere
D64.0 Hereditary sideroblastic anemia
D64.1 Secondary sideroblastic anemia due to disease
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
